Search Page

1

Cite

Share

Adjuvants: Classification, Modus Operandi, and Licensing.

Apostólico Jde S, Lunardelli VA, Coirada FC, Boscardin SB, Rosa DS. Apostólico Jde S, et al. Among authors: boscardin sb. J Immunol Res. 2016;2016:1459394. doi: 10.1155/2016/1459394. Epub 2016 May 4. J Immunol Res. 2016. PMID: 27274998 Free PMC article. Review.

Cite

Share

2

Cite

Share

Editorial: Harnessing the Participation of Dendritic Cells in Immunity and Tolerance.

Boscardin SB, Dudziak D, Münz C, Rosa DS. Boscardin SB, et al. Front Immunol. 2020 Oct 7;11:595841. doi: 10.3389/fimmu.2020.595841. eCollection 2020. Front Immunol. 2020. PMID: 33117409 Free PMC article. No abstract available.

Cite

Share

3

Cite

Share

Sleep Disturbance during Infection Compromises Tfh Differentiation and Impacts Host Immunity.

Fernandes ER, Barbosa ML, Amaral MP, de Souza Apostolico J, Sulczewski FB, Tufik S, Andersen ML, Boscardin SB, Keller AC, Rosa DS. Fernandes ER, et al. Among authors: boscardin sb. iScience. 2020 Sep 23;23(10):101599. doi: 10.1016/j.isci.2020.101599. eCollection 2020 Oct 23. iScience. 2020. PMID: 33205014 Free PMC article.

Cite

Share

4

Cite

Share

Dendritic Cells in Tolerance and Immunity against Pathogens.

Boscardin SB, Rosa DS, Kamphorst AO, Trumpfheller C. Boscardin SB, et al. J Immunol Res. 2016;2016:6438036. doi: 10.1155/2016/6438036. Epub 2016 Mar 31. J Immunol Res. 2016. PMID: 27127796 Free PMC article. No abstract available.

Cite

Share

5

Cite

Share

Dendritic Cells and Their Multiple Roles during Malaria Infection.

Amorim KN, Chagas DC, Sulczewski FB, Boscardin SB. Amorim KN, et al. Among authors: boscardin sb. J Immunol Res. 2016;2016:2926436. doi: 10.1155/2016/2926436. Epub 2016 Mar 24. J Immunol Res. 2016. PMID: 27110574 Free PMC article. Review.

Cite

Share

6

Cite

Share

Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine.

Apostólico JS, Lunardelli VAS, Yamamoto MM, Cunha-Neto E, Boscardin SB, Rosa DS. Apostólico JS, et al. Among authors: boscardin sb. Front Immunol. 2019 Apr 24;10:843. doi: 10.3389/fimmu.2019.00843. eCollection 2019. Front Immunol. 2019. PMID: 31105693 Free PMC article.

Cite

Share

7

Cite

Share

An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo.

Aliprandini E, Takata DY, Lepique A, Kalil J, Boscardin SB, Moro AM. Aliprandini E, et al. Among authors: boscardin sb. Toxicon X. 2019 Jan 18;2:100006. doi: 10.1016/j.toxcx.2019.100006. eCollection 2019 Apr. Toxicon X. 2019. PMID: 32550563 Free PMC article.

Cite

Share

8

Cite

Share

Protective Immunity in Mice Immunized With P. vivax MSP1₁₉-Based Formulations and Challenged With P. berghei Expressing PvMSP1₁₉.

Dobrescu I, de Camargo TM, Gimenez AM, Murillo O, Amorim KNDS, Marinho CRF, Soares IS, Boscardin SB, Bargieri DY. Dobrescu I, et al. Among authors: boscardin sb. Front Immunol. 2020 Feb 19;11:28. doi: 10.3389/fimmu.2020.00028. eCollection 2020. Front Immunol. 2020. PMID: 32153555 Free PMC article.

Cite

Share

9

Cite

Share

Intradermal Delivery of Dendritic Cell-Targeting Chimeric mAbs Genetically Fused to Type 2 Dengue Virus Nonstructural Protein 1.

Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RPDS, Andreata-Santos R, Sousa FTG, Yamamoto MM, Castro-Amarante MF, Favaro MTP, Romano CM, Sabino EC, Boscardin SB, Ferreira LCS. Pereira LR, et al. Among authors: boscardin sb. Vaccines (Basel). 2020 Oct 1;8(4):565. doi: 10.3390/vaccines8040565. Vaccines (Basel). 2020. PMID: 33019498 Free PMC article.

Cite

Share

10

Cite

Share

The dengue virus non-structural 1 protein: risks and benefits.

Amorim JH, Alves RP, Boscardin SB, Ferreira LC. Amorim JH, et al. Among authors: boscardin sb. Virus Res. 2014 Mar 6;181:53-60. doi: 10.1016/j.virusres.2014.01.001. Epub 2014 Jan 13. Virus Res. 2014. PMID: 24434336 Review.

Cite

Share